V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20212828 | 20079385 | 1.73 | 91.8 | Neo-adjuvant (N) | 2021-05-04 | 2021-05-20 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100803071 |
| 20212829 | 20079386 | 1.94 | 67 | null | 2019-02-17 | 2019-02-17 | Capecitabine (21days) + Carboplatin | N | null | CAPECITABINE + CARBOPLATIN | 101599070 |
| 20212830 | 20079387 | 1.7 | 60 | Palliative (P) | 2018-02-24 | 2018-03-05 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 100300272 |
| 20212833 | 20079388 | 1.77 | 47 | Neo-adjuvant (N) | 2018-04-11 | 2018-05-05 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100140294 |
| 20212834 | 20079389 | 1.7 | 97.9 | Curative (C) | 2016-11-02 | 2016-11-11 | Doxorubicin chemoembolisation | null | N | DOXORUBICIN EMBOLISATION | 100215895 |
| 20212835 | 20079390 | 1.65 | 52.5 | null | 2016-04-01 | 2016-04-09 | Capecitabine (21days) + Carboplatin | 02 | null | CAPECITABINE + CARBOPLATIN | 100402343 |
| 20212836 | 20079391 | 1.77 | 54.1 | null | 2019-05-26 | 2019-06-23 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100902930 |
| 20212838 | 20079392 | 1.65 | 103.2 | Curative (C) | 2018-09-07 | 2018-09-16 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100996873 |
| 20212839 | 20079393 | 1.5 | 78.5 | Curative (C) | 2016-08-27 | 2016-08-27 | Capecitabine (21days) + Carboplatin | N | N | CAPECITABINE + CARBOPLATIN | 100409557 |
| 20212841 | 20079394 | 1.6 | 56 | null | 2017-08-11 | 2017-08-25 | CAPECITABINE + CARBOPLATIN | 02 | N | DOXORUBICIN EMBOLISATION | 101741467 |
| 20212842 | 20079395 | 1.49 | 131 | Palliative (P) | 2016-09-21 | 2016-09-27 | Doxorubicin chemoembolisation | null | N | DOXORUBICIN EMBOLISATION | 100237198 |
| 20212843 | 20079396 | 1.68 | 78.9 | null | 2018-12-18 | 2018-12-18 | Cisplatin + Fluorouracil + RT 5day | N | null | CISPLATIN + FLUOROURACIL | 100275752 |
| 20212844 | 20079397 | 1.74 | 81.9 | Curative (C) | 2017-10-17 | 2017-10-20 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100423380 |
| 20212845 | 20079398 | 1.78 | 88.2 | Neo-adjuvant (N) | 2018-07-30 | 2018-09-10 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101277424 |
| 20212846 | 20079399 | 1.73 | 83.4 | Neo-adjuvant (N) | 2018-08-08 | 2018-08-11 | CAPECITABINE + CARBOPLATIN | N | N | CAPECITABINE + CARBOPLATIN | 101212490 |
| 20212847 | 20079400 | 1.72 | 77.6 | Neo-adjuvant (N) | 2015-06-06 | 2015-06-21 | Cisplatin +Fluorouracil (3 wk) | N | N | CISPLATIN + FLUOROURACIL | 101052939 |
| 20212848 | 20079401 | 0 | 42.1 | Neo-adjuvant (N) | 2019-12-11 | 2019-12-11 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 101255836 |
| 20212849 | 20079402 | 1.57 | 55.9 | Neo-adjuvant (N) | 2018-11-10 | 2018-11-20 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 100859830 |
| 20212850 | 20079403 | 1.71 | 81 | Neo-adjuvant (N) | 2017-08-14 | 2017-08-17 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100799360 |
| 20212851 | 20079404 | 1.8 | 74 | Neo-adjuvant (N) | 2016-02-16 | 2016-02-20 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 101172528 |
| 20212853 | 20079405 | 1.72 | 52.5 | Palliative (P) | 2019-09-29 | 2019-10-13 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100559658 |
| 20212854 | 20079406 | 1.65 | 48.15 | Palliative (P) | 2019-12-03 | 2019-12-03 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 101413603 |
| 20212857 | 20079407 | 1.52 | 78.6 | Palliative (P) | 2018-06-05 | 2018-06-27 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 100019830 |
| 20212858 | 20079408 | 1.83 | 62.6 | Curative (C) | 2016-05-11 | 2016-05-14 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 100083696 |
| 20212859 | 20079409 | 1.77 | 50.9 | Palliative (P) | 2017-01-29 | 2017-01-31 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 101015457 |
| 20212860 | 20079410 | 0 | 0 | Palliative (P) | 2018-09-14 | 2018-09-26 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100149542 |
| 20212861 | 20079411 | 1.73 | 80 | Palliative (P) | 2018-06-14 | 2018-06-14 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 100403609 |
| 20212862 | 20079412 | 0 | 0 | null | 2018-06-26 | 2018-07-16 | Doxorubicin chemoembolisation | N | null | DOXORUBICIN EMBOLISATION | 101260720 |
| 20212863 | 20079413 | 0 | 0 | Palliative (P) | 2017-11-12 | 2017-11-21 | Doxorubicin chemoembolisation | 99 | null | DOXORUBICIN EMBOLISATION | 100132208 |
| 20212865 | 20079414 | 1.57 | 49 | Curative (C) | 2019-07-17 | 2019-08-04 | CISPLATIN + FLUOROURACIL | 02 | Y | CISPLATIN + FLUOROURACIL | 100566108 |
| 20212866 | 20079415 | 0 | 52.6 | Palliative (P) | 2017-06-06 | 2017-06-12 | Capecitabine + Carboplatin + RT | N | null | CAPECITABINE + CARBOPLATIN | 101070757 |
| 20212867 | 20079416 | 1.8 | 41.1 | Curative (C) | 2018-08-21 | 2018-09-17 | Doxorubicin chemoembolisation | 02 | Y | DOXORUBICIN EMBOLISATION | 100170332 |
| 20212868 | 20079417 | 1.57 | 100.5 | Adjuvant (A) | 2017-09-01 | 2017-09-07 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 100754210 |
| 20212869 | 20079418 | null | null | Neo-adjuvant (N) | 2018-04-01 | 2018-04-28 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 100755786 |
| 20212870 | 20079419 | 0 | 0 | Neo-adjuvant (N) | null | 2018-07-11 | CAPECITABINE + CARBOPLATIN | 02 | N | DOXORUBICIN EMBOLISATION | 101146673 |
| 20212872 | 20079420 | 1.7 | 63 | Neo-adjuvant (N) | 2019-02-18 | 2019-03-04 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100448587 |
| 20212874 | 20079421 | 1.74 | 55.5 | Neo-adjuvant (N) | 2016-10-02 | 2016-10-06 | CISPLATIN + FLUOROURACIL | N | N | CISPLATIN + FLUOROURACIL | 101303407 |
| 20212875 | 20079422 | 1.63 | 64.6 | Palliative (P) | 2020-04-23 | 2020-04-26 | Trial Unspecified | 01 | Y | TRIAL UNSPECIFIED | 100292052 |
| 20212876 | 20079423 | 1.67 | 58 | Curative (C) | 2019-11-16 | 2019-11-30 | Capecitabine (21days) + Carboplatin | 02 | Y | CISPLATIN + FLUOROURACIL | 100568381 |
| 20212877 | 20079424 | 1.61 | 98 | 03 | 2018-09-30 | 2018-10-11 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100504293 |
| 20212878 | 20079425 | 0 | 0 | Curative (C) | 2021-07-20 | 2021-08-26 | Doxorubicin chemoembolisation | 99 | Y | DOXORUBICIN EMBOLISATION | 100959742 |
| 20212879 | 20079426 | 1.7 | 44.6 | null | 2018-10-07 | 2018-10-25 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101066218 |
| 20212880 | 20079427 | 1.69 | 105.6 | Curative (C) | 2018-07-19 | 2018-08-08 | Trial Unspecified | 01 | Y | TRIAL UNSPECIFIED | 100946783 |
| 20212881 | 20079428 | 1.57 | 56 | Neo-adjuvant (N) | 2018-10-03 | 2018-10-21 | Capecitabine + Carboplatin + RT | 02 | N | CAPECITABINE + CARBOPLATIN | 100825570 |
| 20212882 | 20079429 | 1.69 | 64.4 | Adjuvant (A) | 2016-12-03 | 2016-12-06 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 101767716 |
| 20212883 | 20079430 | 0 | 0 | Palliative (P) | 2021-01-09 | 2021-02-07 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100833333 |
| 20212884 | 20079431 | 1.78 | 67.6 | Palliative (P) | 2018-04-13 | 2018-04-16 | CAPECITABINE + CARBOPLATIN | 02 | N | TRIAL UNSPECIFIED | 101504953 |
| 20212885 | 20079432 | 1.78 | 63.3 | Neo-adjuvant (N) | 2018-05-09 | 2018-05-09 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100419913 |
| 20212886 | 20079433 | 1.78 | 85.5 | Curative (C) | 2019-08-23 | 2019-08-25 | Trial Unspecified | 01 | Y | TRIAL UNSPECIFIED | 101555059 |
| 20212887 | 20079434 | 0 | 0 | Palliative (P) | 2016-08-22 | 2016-09-04 | Capecitabine (21days) + Carboplatin | N | N | DOXORUBICIN EMBOLISATION | 101719179 |